Crum Brian T (CIK 1792747) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy LXRX (33,457 shares), Buy LXRX (69,386 shares), Buy LXRX (170,163 shares), Sell LXRX (105,019 shares), Buy LXRX (26,097 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Buy | 33,457 | $0 |
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Buy | 69,386 | $0 |
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Buy | 170,163 | $0 |
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Sell | 105,019 | $154,378 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Buy | 26,097 | $0 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Buy | 33,456 | $0 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Buy | 69,387 | $0 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, General Counsel & Secr. | Sell | 45,622 | $30,567 |
Source: SEC Form 4 filings · as of 2026-03-03